| MORF Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MORF shares outstanding history going back to 6/27/2019:
Also see: MORF Market Cap History MORF YTD Return |
As of 7/23/2024 Morphic Holding has 50.22 million MORF shares outstanding. Investors often track the MORF shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows MORF share count trends over time, with 24 historical shares outstanding datapoints presented, dating back to 6/27/2019.

| MORF Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the MORF shares outstanding history going back to 6/27/2019:
Also see: MORF Market Cap History MORF YTD Return |
| MORF Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
MORF Historical Shares Outstanding: +11.73% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| MORF Stock Price Chart |
| About Morphic Holding Inc |
| Morphic is a biopharmaceutical company. Co. is applying its proprietary insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with various approved injectable blockbuster drugs for the treatment of chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. Co. is developing its pipeline, including its main product candidate, MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation, into clinical development for the treatment of inflammatory bowel disease. Co. has also developed selective oral avß6-specific integrin inhibitors including MORF-720 and MORF-627. We show 24 historical shares outstanding datapoints in our coverage of MORF's shares outstanding history. Understanding the changing numbers of MORF shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MORF versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MORF by allowing them to research MORF shares outstanding history as well as any other stock in our coverage universe. |
| MORF Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| MORF Share Performance |
| Shares Outstanding Peers |
| Morphic Holding (MORF) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
MOTS Shares Outstanding History MOVE Shares Outstanding History MRIC Shares Outstanding History MRK Shares Outstanding History MRKR Shares Outstanding History MRNA Shares Outstanding History MRNS Shares Outstanding History MRSN Shares Outstanding History MRTX Shares Outstanding History MRVI Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.